Hussain A, Jiang S, Varghese D, Appukkuttan S, et al. Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States. BMC Cancer 2022;22:304.
PMID: 35317768